Ameritas Investment Partners, Inc. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$29,000
-23.7%
7,5610.0%0.00%0.0%
Q4 2019$38,000
+22.6%
7,561
+22.5%
0.00%
+100.0%
Q3 2019$31,000
-13.9%
6,171
+5.1%
0.00%
-50.0%
Q2 2019$36,000
+33.3%
5,8710.0%0.00%
+100.0%
Q1 2019$27,000
+8.0%
5,8710.0%0.00%0.0%
Q4 2018$25,000
-32.4%
5,8710.0%0.00%
-50.0%
Q3 2018$37,000
-21.3%
5,8710.0%0.00%0.0%
Q2 2018$47,000
+6.8%
5,8710.0%0.00%0.0%
Q1 2018$44,000
+25.7%
5,8710.0%0.00%0.0%
Q4 2017$35,000
-10.3%
5,8710.0%0.00%0.0%
Q3 2017$39,000
-2.5%
5,8710.0%0.00%0.0%
Q2 2017$40,000
-27.3%
5,8710.0%0.00%
-33.3%
Q1 2017$55,0005,8710.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders